IE912227A1 - Method and device for the treatment of epilepsy - Google Patents

Method and device for the treatment of epilepsy

Info

Publication number
IE912227A1
IE912227A1 IE222791A IE222791A IE912227A1 IE 912227 A1 IE912227 A1 IE 912227A1 IE 222791 A IE222791 A IE 222791A IE 222791 A IE222791 A IE 222791A IE 912227 A1 IE912227 A1 IE 912227A1
Authority
IE
Ireland
Prior art keywords
fact
accordance
pulses
electrodes
positive
Prior art date
Application number
IE222791A
Original Assignee
Verhoeven Jean Marie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Verhoeven Jean Marie filed Critical Verhoeven Jean Marie
Publication of IE912227A1 publication Critical patent/IE912227A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/36128Control systems
    • A61N1/36146Control systems specified by the stimulation parameters
    • A61N1/36167Timing, e.g. stimulation onset
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/3606Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
    • A61N1/36064Epilepsy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/36128Control systems
    • A61N1/36146Control systems specified by the stimulation parameters
    • A61N1/3615Intensity
    • A61N1/36153Voltage
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/3606Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
    • A61N1/36082Cognitive or psychiatric applications, e.g. dementia or Alzheimer's disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Radiology & Medical Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Electrotherapy Devices (AREA)

Abstract

A therapeutical apparatus for treating epilepsy or related diseases includes a positive electrical impulse generator using electrodes to apply impulses to the head of a patient, with said impulses having a frequency of 1.5-28 Hz, a peak voltage of 1-190 volts and a length of 0.025-2.5 ms.

Description

This invention concerns a method and associated device for the treataent of epilepsy by means of electric pulses applied to the head via electrodes.
It Is known that electric pulses can, in certain cases, be used to treat patients stricken with epilepsy, particularly by means of implanted electrodes. furthermore, frequencies In the Mhz (megahertz) range are used for various other therapeutic purposes.
It has now been determined that higher, unexpected efficacy can be achieved by utilising a method and a device characterized by the fact that pulses, with a repetition frequency in the 1.5 - 28 Hz (hertz) range, are transmitted to the patient via electrodes simply applied to the patient's head. The pulses can be positive or negative in polarity. According to one specific method of operating the invention, the polarity of the pulses is preferably positive.
FAX •2-51Z7241 PAGE 03 era e ? an C': E »c » ' E Γ t: ·· ϋ F U t: • »·! tj P r] The pulees can also be multiple pulses with different repetition frequencies, employed either sequentially or alternately, or even by using a carrier frequency or one frequency nodulated by another.
According to one specific aethod of the invention, a waveform that la basically a negative square wave is superimposed on a pulse that is normally positive, in such a way that the energy of the negative portion of the composite waveform is essentially equal to the energy of the positive portion. Any resulting electrolysis phenomenon can be overcome.
According to the invention, electrodes applied to the IS patient's head transmit electric pulses with a low repetition frequency, in the range mentioned above, and with an amplitude between l - i?o volts (peak).
The width of the pulses, which can vary froa 0.025 ms 20 (milliseconds) to 2.5 ms, is optimally in the 0.20 - 0.30 mm range. A pulse width of 0.25 ms (t 0.1 ms) has been used with good results.
Three electrodes are used for optimum effect, e.g., one positive frontal electrode and two negative electrodes at the base of the nucha. More than three electrodes can also be used.
IE 912227 jgnion ξη PAX 32-2-513241 PAGE 04 Patients are typically treated in two consecutive sessions, each lasting approximately 10 minutes. A pulse repetition frequency of 1.5 Hz (or approximately 1.5 Hz) is used during the first lo-ninute session, and e frequency of 2ft Hz (or approximately 28 Hz) is used for the second 10-minute session. The pulse amplitude, which can be adapted to each individual case, can vary between 1 - 170 volts (peek I .
A reduction in the number of crises has been noted for epileptic patients who have been so treated. For most of these cases in which neo-encephalographic monitoring (computer-controlled electroencephalography) has been employed, an Improvement in cerebral electric activity has been noted. Some patients have responded positively to this method when other therapies proved ineffective.
The pulse generator used in operating the invention ean easily he designed by a person skilled In electronics.
The device used for operating the invention can be powered by a single 6-volt battery protected by a fuse. The battery is rechargeable from the mains· protective circuitry prevents the device from being operated directly from the meins.
GUGNION GA FAX 32-2-51ZT241 PAGE 05 i. ζ z.
F >< Ϊ ί t X ? J In on· specific version, ch· device includes· two singlechannel input jacks; two potentiometers, one ot which is equipped with an on-off switch; and various digital displays- The device is thus optimally provided with a frequency display, a current display, a resistance display, and a voltage display. The device can also be provided with a battery charge level indicator. In order to prevent any preaature damage to the battery, it is automatically disconnected from the circuit when the battery voltage drops to 4.5 volts.
The voltneter and ammeter indicate peak values of voltage and current, respectively. The ohameter indicates the value of the voltage divided by the value of the current (R · v/1). The ohmmeter reading is meaningful only for significant values of v and 1.
The device is optimally compact and transportable.
Figure 1 shows the pulse shape under no-load (A) and load (B> conditions. * t K V; £: » h J · t L. 3IJGNI0N 3A 32-2-5137241 The block diagram of Fig. 2 shows the invention in a typical configuration. The reference numbers on the diagram correspond to the following components! 1 220-volt mains supply 2 rectlfier/oharglng circuit 3 control circuit 4 battery 5 relay 10 6 power supply 7 frequency adjustment 9 oscillator 9 frequency meter 10 wave-shaping circuit 15 11 adjustment 12 buffer amplifier 13 output connections for electrodes 14 current buffer 15 voltage buffer 20 16 voltage memory 17 current memory 16 control circuit 19 v/1 divider circuit 20 ohmmeter 25 21 voltmeter 22 ammeter Several other equivalent schematics can be adopted within the context of the invention.
PAGE Ufa lUGNION Sh 32-2-5137241 PAGE d' ir i ι<·γ«τ«-. II ·!« ο'-,ιηυ « ••Μ»νβ»ΓΊΤ*Ίΐ·τ.υ·«Ί,ηΐηΐΛΓί·«!Γ«Μ,*ϊ«»Γ'η|’«1’!νν»ννΗ'’·«ί11Μη*η··Μ;ρ« <('

Claims (14)

CLAIMS 1) Device intended for therapeutic use, characterized by 5 the fact that it includes an electric pulse generator and electrodes for applying said electric pulses to the patient's head; the pulses coning from the electrodes have a frequency repetition rate between
1.5 - 28 HZ; the voltage of these pulses varies from 10 1 - 190 volts (peak), and the pulse width is between 0.025 - 2.5 ms.
2. ) Device, in accordance with Claia l, characterized by the fact that the pulses are positive.
3. ) Device, in accordance with Claims 1 & 2, for the treatment of epilepsy and related illnesses.
4. ) Device, in accordance with Claims 1 - 3, characterized 20 by the fact the pulses are multiple pulses comprised of different repetition frequencies, employed either sequentially or alternately, or even by using a carrier frequency or one frequency modulated by another.
5. ) Device, in accordance with Claims 1-4, characterized by the fact the width of the pulses falls within the range 0.20 0.30 ms . 61 Device, in accordance with Claim 5, characterized by the fact that the pulse width is 0,25 ms. 7} Device, In accordance with Claims 1-6, characterized 5 by the fact that it incorporates at least three electrodes applied to the patient's head.
6. 8) Device, in accordance with Claim 7, characterized by the fact that two electrodes are negative and one 10 electrode Is positive.
7. 9) Device, in accordance with any of Claims 1-8, characterized by the fact that it includes the electronics circuits shown In Pig. 2, or the 15 equivalent thereof.
8. 10) Device, in accordance with claim l, characterized by the fact that a negative waveform is superimposed on electric pulses that are normally positive.
9. 11) Device, in accordance with claim 9, characterized by the fact that the waveform is essentially a negative square wave. 25
10. 12) Device, in accordance with Claim· 9 or 10, characterized by the fact that the energy content of the negative square wave is essentially equal to that of the positive portion. -ί .imam,anti 30 35yd XUd bS NOINana
11. 13) Use of a device, .n accordance with Claims 1 - 12, far the treatment of epilepsy or related lllneaaee.
12. 14) Method of treatment of the human body characterized by 5 the fact that at least two electrodes are applied to the head of an epileptic patient, and that said electrodes emit positive electric pulses, the width of which varies between 0.025 - 25 ms; the amplitude of said pulses varies between 1 - 170 volts; the 10 repetition frequency of said pulses varies between 1 -100 Hz, and optimally lies in the 1.5 - 28 Hz range. IS 00 33bd ΐΡΖάζτς-Ξ-Ξ£ xbd bS ΝΟΙΝ9Π0
13. 15) A device substantially as hereinbefore described with reference to the drawings.
14. 16) A method of treatment substantially as hereinbefore described with reference to the drawings.
IE222791A 1990-06-28 1991-06-26 Method and device for the treatment of epilepsy IE912227A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BE9000660 1990-06-28
BE9100054 1991-01-23

Publications (1)

Publication Number Publication Date
IE912227A1 true IE912227A1 (en) 1992-01-01

Family

ID=25662538

Family Applications (1)

Application Number Title Priority Date Filing Date
IE222791A IE912227A1 (en) 1990-06-28 1991-06-26 Method and device for the treatment of epilepsy

Country Status (10)

Country Link
EP (1) EP0489879A1 (en)
JP (1) JPH05502608A (en)
AU (1) AU8095491A (en)
CA (1) CA2065388A1 (en)
IE (1) IE912227A1 (en)
IL (1) IL98656A0 (en)
MX (1) MX9100005A (en)
NO (1) NO920780D0 (en)
PT (1) PT98122A (en)
WO (1) WO1992000119A1 (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5752979A (en) * 1996-11-01 1998-05-19 Medtronic, Inc. Method of controlling epilepsy by brain stimulation
US8762065B2 (en) 1998-08-05 2014-06-24 Cyberonics, Inc. Closed-loop feedback-driven neuromodulation
US9415222B2 (en) 1998-08-05 2016-08-16 Cyberonics, Inc. Monitoring an epilepsy disease state with a supervisory module
US9113801B2 (en) 1998-08-05 2015-08-25 Cyberonics, Inc. Methods and systems for continuous EEG monitoring
US9042988B2 (en) 1998-08-05 2015-05-26 Cyberonics, Inc. Closed-loop vagus nerve stimulation
US7747325B2 (en) 1998-08-05 2010-06-29 Neurovista Corporation Systems and methods for monitoring a patient's neurological disease state
US9375573B2 (en) 1998-08-05 2016-06-28 Cyberonics, Inc. Systems and methods for monitoring a patient's neurological disease state
US7209787B2 (en) 1998-08-05 2007-04-24 Bioneuronics Corporation Apparatus and method for closed-loop intracranial stimulation for optimal control of neurological disease
DE10300069A1 (en) * 2003-01-03 2004-07-22 Grönemeyer, Dietrich H. W., Prof. Dr.med. EP trainer
US8725243B2 (en) 2005-12-28 2014-05-13 Cyberonics, Inc. Methods and systems for recommending an appropriate pharmacological treatment to a patient for managing epilepsy and other neurological disorders
US8868172B2 (en) 2005-12-28 2014-10-21 Cyberonics, Inc. Methods and systems for recommending an appropriate action to a patient for managing epilepsy and other neurological disorders
US7676263B2 (en) 2006-06-23 2010-03-09 Neurovista Corporation Minimally invasive system for selecting patient-specific therapy parameters
US8295934B2 (en) 2006-11-14 2012-10-23 Neurovista Corporation Systems and methods of reducing artifact in neurological stimulation systems
US20080183097A1 (en) 2007-01-25 2008-07-31 Leyde Kent W Methods and Systems for Measuring a Subject's Susceptibility to a Seizure
WO2008092119A2 (en) 2007-01-25 2008-07-31 Neurovista Corporation Systems and methods for identifying a contra-ictal condition in a subject
US8036736B2 (en) 2007-03-21 2011-10-11 Neuro Vista Corporation Implantable systems and methods for identifying a contra-ictal condition in a subject
US9788744B2 (en) 2007-07-27 2017-10-17 Cyberonics, Inc. Systems for monitoring brain activity and patient advisory device
US9259591B2 (en) 2007-12-28 2016-02-16 Cyberonics, Inc. Housing for an implantable medical device
US20090171168A1 (en) 2007-12-28 2009-07-02 Leyde Kent W Systems and Method for Recording Clinical Manifestations of a Seizure
US8849390B2 (en) 2008-12-29 2014-09-30 Cyberonics, Inc. Processing for multi-channel signals
US8588933B2 (en) 2009-01-09 2013-11-19 Cyberonics, Inc. Medical lead termination sleeve for implantable medical devices
US8786624B2 (en) 2009-06-02 2014-07-22 Cyberonics, Inc. Processing for multi-channel signals
US9643019B2 (en) 2010-02-12 2017-05-09 Cyberonics, Inc. Neurological monitoring and alerts

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3918461A (en) * 1974-01-31 1975-11-11 Irving S Cooper Method for electrically stimulating the human brain
EP0156854B1 (en) * 1983-09-14 1990-09-05 ZABARA, Jacob Neurocybernetic prosthesis
US4646744A (en) * 1984-06-29 1987-03-03 Zion Foundation Method and treatment with transcranially applied electrical signals
EP0272318A1 (en) * 1986-06-16 1988-06-29 Elefant, Mordecai Method and apparatus for delivering a prescriptive electrical signal
GB8904998D0 (en) * 1989-03-04 1989-04-19 Matthews Tony Anaesthetising apparatus

Also Published As

Publication number Publication date
IL98656A0 (en) 1992-07-15
AU8095491A (en) 1992-01-23
NO920780L (en) 1992-02-27
CA2065388A1 (en) 1991-12-29
WO1992000119A1 (en) 1992-01-09
JPH05502608A (en) 1993-05-13
PT98122A (en) 1993-09-30
MX9100005A (en) 1992-02-03
EP0489879A1 (en) 1992-06-17
NO920780D0 (en) 1992-02-27

Similar Documents

Publication Publication Date Title
IE912227A1 (en) Method and device for the treatment of epilepsy
EP0164016B1 (en) Apparatus for treating neurovegatative disorders
US3902502A (en) Apparatus for temporarily arresting arthritic pain
US5217009A (en) Compact biomedical pulsed signal generator for bone tissue stimulation
US4993413A (en) Method and apparatus for inducing a current and voltage in living tissue
US4723552A (en) Transcutaneous electrical nerve stimulation device
US4431002A (en) Modulated deep afferent stimulator
EP1427474B1 (en) Apparatus for bioelectric stimulation, healing acceleration and pain relief
CA1319174C (en) Electrical nerve stimulation device for nausea control
US4018218A (en) Method and apparatus for sleep induction
EP0309093A1 (en) Low-frequency electrotherapeutic device
ATE145343T1 (en) ELECTROTHERAPY DEVICE
US20140277323A1 (en) Oral neural stimulator
LLOYD et al. A review of the use of electro-motor stimulation in human muscles
US4249537A (en) Current controlled muscle stimulator
IE850517L (en) Heart pacer. diacylhydrazine derivatives.
US3896817A (en) Implantable nerve stimulator
US20020161416A1 (en) Nerves and muscle stimulator
EP0537320A1 (en) Device for carrying out an iontophoresis treatment on a patient.
WO1988006906A1 (en) Device for electroanalgesia of tissues in patients
US3602229A (en) A method of fibrillating a heart and apparatus therefor
EP0099662A1 (en) Transcutaneous electrical nerve stimulation apparatus
US6792313B2 (en) Muscle stimulation in a cast immobilized limo
US6856837B2 (en) Method and device for electrochemically building of muscle
Higashiyama et al. Perceived locus and intensity of electrocutaneous stimulation